< Back to previous page
Researcher
Davide Aloi
- Disciplines:Physiology
Affiliations
- Laboratory of Ion Channel Research (VIB-KU Leuven) (Division)
Member
From1 Oct 2017 → 25 Dec 2022
Projects
1 - 1 of 1
- TRPM3 as novel target to alleviate acute oxaliplatin-induced peripheral neuropathy.From2 Oct 2017 → 25 Nov 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 4 of 4
- TRPM3 as a novel target to alleviate acute oxaliplatin-induced peripheral neuropathic pain(2023)
Authors: Davide Aloi, Thomas Voets, Joris Vriens
Pages: 2060 - 2069 - TRPM3 as novel target to alleviate acute oxaliplatin-induced peripheral neuropathy.(2022)
Authors: Davide Aloi, Joris Vriens, Thomas Voets
Number of pages: 10 - Pharmacological properties of TRPM3 isoforms are determined by the length of the pore loop(2022)
Authors: Kathi Held, Davide Aloi, Annelies Janssens, Thomas Voets, Joris Vriens
Pages: 3560 - 3575 - Mutations in the voltage-sensing domain affect the alternative ion permeation pathway in the TRPM3 channel(2018)
Authors: Kathi Held, Fabian Gruss, Davide Aloi, Annelies Janssens, Chris Ulens, Thomas Voets, Joris Vriens
Pages: 2413 - 2432